Primary CNS Lymphoma (MSK, Clin Cancer Res 2024)

Summary

Primary CNS Lymphoma (MSK, Clin Cancer Res 2024) is a study catalogued by cBioPortal DataHub under the cancer-type code pcnsl. EvidenceHelix groups it with brain and nervous system studies.

Study description

Targeted sequencing of 86 samples from 44 patients with primary CNS lymphoma with their matched normals via HemePACT. A Phase II study assessing Long-Term Response to Ibrutinib Monotherapy in recurrent or refractory CNS Lymphoma. A Phase II study assessing Long-Term Response to Ibrutinib Monotherapy in recurrent or refractory CNS Lymphoma.

Text as published in the source's study metadata.

Citation & PubMed

Grommes, Christian et al. Clin Cancer Res 2024

Linked PubMed records: PMID 38995739

Source & licence

Metadata from cBioPortal DataHub at e1b75cd25b, available under the ODC Open Database License (ODbL) 1.0. See the Source metadata tab for every field.

Source metadata

Study identifier

pcnsl_msk_2024

Short name

not given

Source cancer-type code

pcnsl

Reference genome

not given

Source access groups

not given

Original study

View on cBioPortal

Metadata file

meta_study.txt at e1b75cd25b

Database licence

ODC Open Database License (ODbL) 1.0

Study-level metadata only (title, description, cancer-type code, citation, PubMed ids). No patient, sample, mutation or clinical data, and no publication full text, is included. Individual studies may carry their own terms; follow each study's source links before reusing its data.

Citations

Grommes, Christian et al. Clin Cancer Res 2024

• PubMed record 38995739 ↗

Citation counts are not part of the source metadata and are not shown.

Related studies

• Anaplastic Oligodendroglioma and Anaplastic Oligoastrocytoma (MSK, Neuro Oncol 2017)

  IMPACT sequencing of 22 Anaplastic Oligodendroglioma and Anaplastic Oligoastrocytomas.

  Brain and nervous systemMSK studiesSource code difgPubMed 1

• Glioma (MSK, Clin Cancer Res 2019)

  Targeted sequencing on MSK-IMPACT and FMI Panels of 1004 samples (837 with matched normals) from 923 glioma patients.

  Brain and nervous systemMSK studiesSource code difgPubMed 1

• Glioma (MSK, Nature 2019)

  Targeted Sequencing of CSF samples (91 samples with 86 matched normals) from 42 glioma patients.

  Brain and nervous systemMSK studiesSource code difgPubMed 1

• IDH-mutated Diffuse Glioma (MSK, Clin Cancer Res 2024)

  Targeted sequencing of 73 IDH-mutated low-grade gliomas and their matched normal pairs via MSK-IMPACT. The data is available on Synapse (https://www.synapse.org/#!Synapse:syn52658621/wiki/624065).

  Brain and nervous systemMSK studiesSource code difgPubMed 1

• Malignant Peripheral Nerve Sheath Tumor (MSK, Nat Genet 2014)

  Whole exome sequencing of 15 malignant peripheral nerve sheath tumor/normal pairs.

  Brain and nervous systemMSK studiesSource code mpnstPubMed 1

• Brain Lower Grade Glioma (TCGA, Firehose Legacy)

  TCGA Brain Lower Grade Glioma. Source data from GDAC Firehose (http://gdac.broadinstitute.org/runs/stddata__2016_01_28/data/LGG/20160128/). Previously known as TCGA Provisional.

  Brain and nervous systemTCGA Firehose LegacySource code difg

• Brain Lower Grade Glioma (TCGA, PanCancer Atlas)

  Brain Lower Grade Glioma TCGA PanCancer data. The original data is here (https://gdc.cancer.gov/about-data/publications/pancanatlas). The publications are here (https://www.cell.com/pb-assets/consortium/pancanceratlas…

  Brain and nervous systemTCGA PanCancer AtlasSource code difgPubMed 12

• Brain Tumor PDXs (Mayo Clinic, Clin Cancer Res 2020)

  WES on a total of 106 PDXs and 80 PDXs have the matched germline (blood) samples sequenced. A total of 66 PDXs have RNASeq available

  Brain and nervous systemOther published and consortium studiesSource code difgPubMed 1

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.